Invention Grant
- Patent Title: 2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof
-
Application No.: US15677272Application Date: 2017-08-15
-
Publication No.: US10266528B2Publication Date: 2019-04-23
- Inventor: Richard D. Caldwell
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Grüneberg and Myers PLLC
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; A61K31/437 ; A61K31/553
Abstract:
The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
Public/Granted literature
- US20180051024A1 2-OXO-IMIDAZOPYRIDINES AS REVERSIBLE BTK INHIBITORS AND USES THEREOF Public/Granted day:2018-02-22
Information query
